Results 201 to 210 of about 519,396 (228)
Getting There First With the Best: The Need to Shorten the Prescription Drug Approval Process [PDF]
Kassel, Mark A.
core +1 more source
Infection and infestation-related adverse events of ocrelizumab: A disproportionality analysis using FDA adverse event reporting system. [PDF]
Duman NC.
europepmc +1 more source
A real-world data analysis of Ozanimod in the FDA Adverse Event Reporting System (FAERS) database. [PDF]
Tang Q +6 more
europepmc +1 more source
Vaccine Adverse Event Reporting System--United States.
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The vaccine adverse event reporting system (VAERS)
Vaccine, 1994Immunizations against most vaccine-preventable diseases will be needed indefinitely unless the disease is eradicated. Public acceptance of immunizations may be threatened as vaccine coverage increases and disease decreases, however, due to the increase in both causally and coincidentally related vaccine adverse events.
R T, Chen +6 more
openaire +3 more sources
Antidepressants-related cardiovascular adverse events using the adverse event reporting system
Psychiatry Research, 2018The aim of this study was to evaluate clinical manifestations and the age and sex distribution of cardiovascular adverse events (CVAEs) related to antidepressants. The FDA Adverse Event Reporting System (FAERS) and Korea Adverse Event Reporting System (KAERS) database records on patients prescribed antidepressants were used.
Yoon Kyong, Lee +6 more
openaire +2 more sources
American Journal of Hematology, 2021
AbstractThe U.S. Food and Drug Administration (FDA) approved the first chimeric antigen receptor T‐cell therapy, tisagenlecleucel, in August 2017. We sought to describe adverse events (AEs) reported to the FDA Adverse Event Reporting System (FAERS) for tisagenlecleucel in the post‐marketing period. We searched FAERS reports to identify U.S.
Graça M. Dores +3 more
openaire +2 more sources
AbstractThe U.S. Food and Drug Administration (FDA) approved the first chimeric antigen receptor T‐cell therapy, tisagenlecleucel, in August 2017. We sought to describe adverse events (AEs) reported to the FDA Adverse Event Reporting System (FAERS) for tisagenlecleucel in the post‐marketing period. We searched FAERS reports to identify U.S.
Graça M. Dores +3 more
openaire +2 more sources
Vaccine, 2012
Adverse events following immunization (AEFI) reported to the national Vaccine Adverse Event Reporting System (VAERS) represent true causally related events, as well as events that are temporally, but not necessarily causally related to vaccine.We sought to determine if the causal relationships between the vaccine and the AEFI reported to VAERS could be
Anita M, Loughlin +13 more
openaire +2 more sources
Adverse events following immunization (AEFI) reported to the national Vaccine Adverse Event Reporting System (VAERS) represent true causally related events, as well as events that are temporally, but not necessarily causally related to vaccine.We sought to determine if the causal relationships between the vaccine and the AEFI reported to VAERS could be
Anita M, Loughlin +13 more
openaire +2 more sources
American Journal of Medical Quality, 2018
Physicians underutilize adverse event reporting systems. Web-based platforms have increased participation; thus, it was hypothesized that a mobile application would increase adverse event reporting. The authors developed a mobile reporting application for iOS and Android operating systems and performed a retrospective review on reporting rates by ...
Daniel S, Rubin +4 more
openaire +2 more sources
Physicians underutilize adverse event reporting systems. Web-based platforms have increased participation; thus, it was hypothesized that a mobile application would increase adverse event reporting. The authors developed a mobile reporting application for iOS and Android operating systems and performed a retrospective review on reporting rates by ...
Daniel S, Rubin +4 more
openaire +2 more sources

